BPI 2019 | Cell & Gene Therapy BioProcessing & Commercialization

Boston, MA

Explore new advanced technology solutions for the biomanufacturing of cell, gene and extracellular vesicle therapies

Attending BPI 2019? Be sure to stop by booth #1507 to:

• Learn how to radically simplify the use of human mesenchymal stem/stromal cells (hMSCs) and extracellular vesicles (EVs) with RoosterBio’s next-gen technologies
• Ask us about our new umbilical cord-derived (hUC) MSC product
• Receive some RoosterSwag while supplies last

Join us for talks and poster presentations that include strategies and solutions for rapidly streamlining the path to clinical manufacturing

Featured Talks

September 9, 2019 (Pre-Conference Workshop at Cell & Gene Therapy Meeting)

“Radically Simplifying Scale-Up of hMSCs” under the Tissue track and Next Generation Tools for Manufacturing Medicine Products at Scale

Dr. Taby Ahsan, VP of Analytical, Product & Process Development, RoosterBio

September 10, 2019 (Cell & Gene Therapy Meeting)

“Exosomes and Their Potential for Scalable Manufacturing Platforms” under the Exosomes track and the Pre-Clinical and Clinical Development for Cell, Gene and CAR-T Therapies

Dr. Jon A. Rowley, Founder & Chief Product Officer, RoosterBio

Scientific Posters


Scaling a Xeno-Free Fed-Batch Microcarrier Suspension Bioreactor System to the Production Scale (50L) for Manufacturing XF hMSCs (Download)


MSC-EVs Manufactured in Scalable 3D Bioreactor Systems (Download)